Showing results (361-370 of 389) with videos related to
Sort By:
Pageof 39
Hepatology (Baltimore, Md.)|July 7, 2021
Fatty Acid Synthase-Suppressor Screening Identifies Sorting Nexin 8 as a Therapeutic Target for NAFLDYufeng Hu, Wenzhi He, Yongping Huang, et al.Hepatology (Baltimore, Md.)|April 24, 2021
Hepatocyte SH3RF2 Deficiency Is a Key Aggravator for NAFLDXia Yang, Dating Sun, Hui Xiang, et al.Circulation Research|April 19, 2022
The E3 Ligase TRIM16 Is a Key Suppressor of Pathological Cardiac HypertrophyJiayi Liu, Wei Li, Ke-Qiong Deng, et al.Angewandte Chemie (International Ed. in English)|July 5, 2022
Enhancing Li+ Transport in NMC811||Graphite Lithium-Ion Batteries at Low Temperatures by Using Low-Polarity-Solvent ElectrolytesBo Nan, Long Chen, Nuwanthi D Rodrigo, et al.Cell Metabolism|June 9, 2021
TMBIM1 is an inhibitor of adipogenesis and its depletion promotes adipocyte hyperplasia and improves obesity-related metabolic diseaseGuang-Nian Zhao, Zheng-Wei Tian, Tian Tian, et al.Nature Medicine|December 12, 2017
The deubiquitinating enzyme TNFAIP3 mediates inactivation of hepatic ASK1 and ameliorates nonalcoholic steatohepatitisPeng Zhang, Pi-Xiao Wang, Ling-Ping Zhao, et al.Hepatology (Baltimore, Md.)|June 16, 2021
TNFAIP3 Interacting Protein 3 Is an Activator of Hippo-YAP Signaling Protecting Against Hepatic Ischemia/Reperfusion InjuryJunjie Zhou, Manli Hu, Meiling He, et al.Nature Medicine|May 9, 2017
Tmbim1 is a multivesicular body regulator that protects against non-alcoholic fatty liver disease in mice and monkeys by targeting the lysosomal degradation of Tlr4Guang-Nian Zhao, Peng Zhang, Jun Gong, et al.The Journal of Clinical Investigation|January 11, 2024
TRIM56 protects against nonalcoholic fatty liver disease by promoting the degradation of fatty acid synthaseSuowen Xu, Xiumei Wu, Sichen Wang, et al.Nature Medicine|September 13, 2016
The long noncoding RNA Chaer defines an epigenetic checkpoint in cardiac hypertrophyZhihua Wang, Xiao-Jing Zhang, Yan-Xiao Ji, et al.Pageof 39